Skip to content
← Index board

Health Optimization Index

TUDCA (Tauroursodeoxycholic Acid)

Nick’s assessment
Promising
Research evidence
C, mixed evidence
Attention
3.9 / 100▼ Falling this week
6.7/ 10

BioHarmony score

TUDCA is a taurine-conjugated bile acid with a narrow but defensible liver, bile-flow, and metabolic role; Kars 2010 reported roughly 30% better hepatic and skeletal-muscle insulin sensitivity after 4 weeks in obese T2D. The ALS combination-drug story weakened after Amylyx PHOENIX failed in 2024.

Read the full report Benefits, risks and practical guidance.

Read Nick’s assessment Why it earned this rating

TUDCA earns its score on a narrow, real strength: hepatobiliary support, bile flow, and a single solid metabolic signal, with weaker proof everywhere else. It makes sense when you have a specific liver, bile, or insulin-sensitivity question, can buy a quality product, and can track a concrete before-and-after marker. It makes far less sense as a general detox shortcut or as a way to out-supplement a liver you keep stressing with steroids, alcohol, or junk.

✅ Best for: People targeting bile flow, sluggish digestion, cholestasis-type concerns, or liver and insulin-sensitivity questions, ideally with bloodwork and a clinician in the loop. It fits best when you define the outcome in advance, use a verified product, and stop if the marker does not move.

❌ Avoid if: You are pregnant, take bile-acid or liver medications without medical clearance, or expect TUDCA to fix a healthy liver you are actively damaging. Skip it as a substitute for sleep, nutrition, training, or real medical care. Be especially careful with the ALS angle: AMX0035 (Relyvrio) combined taurursodiol with sodium phenylbutyrate, the PHOENIX Phase 3 trial failed in 2024, and Amylyx pulled the product, so do not treat old ALS optimism as proof that stand-alone TUDCA protects nerves.

Share your experience

Your answers are optional and help other readers — they never change my score. How community input works.

Tried it in real life?

How would you assess it?

Favorable is the strongest rating, followed by Promising, then Experimental. Overhyped means the claims outrun the evidence or interest is fading.

Make a 12-month prediction Will it rise or fall in the Index?

Choose a direction and your confidence. Correct predictions earn leaderboard points.

Your 12-month call on TUDCA (Tauroursodeoxycholic Acid)
How sure are you?

Your prediction is final once submitted. We’ll check it in 12 months. See the leaderboard →

Updated Sep 14, 2026 How the Index ranks →

Educational information, not medical advice. Ask a qualified clinician about risks and interactions. Independent ratings: no affiliate links, sponsored placements or paid rankings.